BETA BIONICS, INC. (BBNX)

19.72 +0.92% (+0.18)

Over 5Y: -16.5%

2026-08-28
10 20 30
2025 2026

Financials Quarterly

Q1 '24 — Revenue: 12.9M Q1 '24 — Operating Cash Flow: -12.1M Q1 '24 — Free Cash Flow: -12.6M Q1 '24 — Net Income: -12.4M Q2 '24 — Revenue: 15M Q2 '24 — Operating Cash Flow: -12.2M Q2 '24 — Free Cash Flow: -12.7M Q2 '24 — Net Income: -14.5M Q3 '24 — Revenue: 16.7M Q3 '24 — Operating Cash Flow: -9.6M Q3 '24 — Free Cash Flow: -11.5M Q3 '24 — Net Income: -9.7M Q4 '24 — Revenue: 20.4M Q4 '24 — Operating Cash Flow: -14.3M Q4 '24 — Free Cash Flow: -14.8M Q4 '24 — Net Income: -18.1M Q1 '25 — Revenue: 17.6M Q1 '25 — Operating Cash Flow: -20M Q1 '25 — Free Cash Flow: -20.3M Q1 '25 — Net Income: -28.7M Q2 '25 — Revenue: 23.2M Q2 '25 — Operating Cash Flow: -13.6M Q2 '25 — Free Cash Flow: -15.4M Q2 '25 — Net Income: -16.9M Q3 '25 — Revenue: 27.3M Q3 '25 — Operating Cash Flow: -8.7M Q3 '25 — Free Cash Flow: -10M Q3 '25 — Net Income: -14.2M Q4 '25 — Revenue: 32.1M Q4 '25 — Operating Cash Flow: -8.6M Q4 '25 — Free Cash Flow: -10.5M Q4 '25 — Net Income: -13.5M Q1 '26 — Revenue: 27.6M Q1 '26 — Operating Cash Flow: -23.8M Q1 '26 — Free Cash Flow: -25.2M Q1 '26 — Net Income: -21.9M Q2 '26 — Revenue: 32M Q2 '26 — Operating Cash Flow: -14.6M Q2 '26 — Free Cash Flow: -15.7M Q2 '26 — Net Income: -23.4M -15M 0 15M 30M 45M
Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.1
SBC / sales 17.8%
OE margin -69.4%
Oper. margin -69.8%
ROIC -86.4%
Accruals -5.9%
Gross margin 58.3%
EBITDA margin -67.9%
FCF margin -51.6%
OCF margin -46.9%
Profit margin -61.3%
ROA -25.0%
ROCE -31.2%
ROE -28.5%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.1
RPO / sales 0.016×
RPO growth 72.7%
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.5
ND/EBITDA —
Cash runway 2.9 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 8.0×
F-score 4.5 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales/sh Y/Y -76.1%
Sales Q/Q +37.8%
Shares change +537.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.